538 studies on GIP agonist class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study provides valuable real-world insights into the comparative safety profiles of tirzepatide, semaglutide, and liraglutide, which can complement findings from controlled clinical trials. The observed differenc…
This study highlights a crucial aspect of Tirzepatide's efficacy: its ability to preserve fat-free mass during weight loss is strongly linked to enhanced glycaemic control. This finding suggests that Tirzepatide offer…
The findings summarized in this review suggest that PentaPeptide-5 and similar multi-receptor agonists represent a significant advancement in the treatment of obesity and type 2 diabetes. By targeting multiple metabol…
This study holds significant promise for improving the health outcomes of people living with HIV who struggle with obesity and chronic inflammation. If successful, the findings could establish tirzepatide as a valuabl…
The discontinuation of GLP-1 agonists often leads to weight regain and a return of metabolic challenges, including elevated triglycerides, which are risk factors for cardiovascular disease. If RDX-002 proves effective…
This ongoing trial is crucial because it addresses a significant unmet medical need, potentially offering a new therapeutic option for adolescent obesity. If successful, the findings could establish tirzepatide as a s…
This study is crucial because it provides real-world evidence supporting Tirzepatide as a highly effective treatment intensification strategy for Type 2 Diabetes patients who are not adequately controlled on GLP-1 RAs…
The study, currently underway, aims to demonstrate the significant efficacy of Tirzepatide in reducing liver fat deposition in patients with Type 2 Diabetes and NAFLD with advanced fibrosis. Based on Tirzepatide's wel…
This research is critically important as it will provide evidence-based guidance for managing incretin-based therapies in patients undergoing upper endoscopy, potentially enhancing patient safety and procedural effici…
This case report highlights a rare but serious adverse event associated with tirzepatide use, particularly in individuals without pre-existing diabetes or obesity. Clinicians must be vigilant for symptoms of ketoacido…
This commentary underscores the critical importance of addressing metabolic comorbidities in inflammatory diseases like psoriatic arthritis. The hypothetical findings suggest that combining an IL-17A inhibitor with a …
This review highlights that obesity pharmacotherapy should be considered a disease-modifying component of Type 2 Diabetes (T2D) care, moving beyond mere weight reduction. The ability of these drugs to improve a broad …
This research provides compelling evidence that GLP-1 receptor agonists could represent a novel and effective strategy for smoking cessation. The observed reductions in nicotine seeking and withdrawal symptoms, couple…
This network meta-analysis provides crucial evidence that could significantly impact clinical guidelines for managing Type 2 Diabetes patients with high cardiovascular risk. The identification of specific GLP-1 recept…
This research provides robust real-world evidence confirming the effectiveness of GLP-1 therapies in a diverse Middle Eastern population, mirroring results from controlled clinical trials. The observed significant red…
This study provides critical safety reassurance regarding the use of these widely prescribed antidiabetic medications, particularly for hematologic malignancy risk. The agent-specific findings highlight the importance…
This case report is highly significant as it identifies a potential rare but serious adverse event associated with tirzepatide use in a patient population not traditionally considered at high risk for ketoacidosis. It…
This review provides strong evidence supporting Tirzepatide's potential as a highly effective therapeutic agent for Metabolically Dysfunctional-Associated Steatohepatitis (MASH), addressing a critical unmet medical ne…
The pervasive and devastating impact of addiction, affecting billions globally and incurring significant health, social, and economic costs, underscores the critical need for innovative treatment strategies. Incretin-…
A deeper understanding of the precise mechanisms underlying beta-cell stress and identity failure is absolutely crucial for the development of novel, disease-modifying therapeutic strategies for type 2 diabetes. This …
This research highlights the critical need for a more personalized approach to semaglutide therapy, moving beyond average treatment effects. Identifying predictors for suboptimal response could enable clinicians to ta…
This review significantly advances our understanding of GLP-1's extensive therapeutic potential, moving beyond its established role in metabolic health. The detailed exploration of its neuroprotective mechanisms sugge…
This research provides critical reassurance regarding the safety and efficacy of GLP-1 receptor agonists for obesity management. The preservation of muscle mass and function during weight loss is a significant clinica…
This study powerfully underscores the chronic nature of obesity and the significant challenge of weight regain following tirzepatide discontinuation, emphasizing that sustained pharmacological intervention may be nece…
This research provides crucial insights into the pleiotropic effects of Retatrutide, extending its known benefits beyond weight loss and glycemic control to direct adipose tissue repair. The ability of Retatrutide to …
This pooled analysis strongly suggests that Tirzepatide is a highly effective add-on therapy for patients with Type 2 Diabetes who are not achieving optimal glycemic control with basal insulin alone. The dual action a…
These findings are highly significant, as they demonstrate that Tirzepatide, a dual GLP-1/GIP receptor agonist, offers substantial benefits beyond glycemic control and weight loss, directly addressing critical cardiov…
This pilot study holds significant promise, as successful integration of weight management strategies could potentially improve treatment efficacy and long-term outcomes for endometrial cancer patients. If tirzepatide…
This pilot study is crucial for understanding Tirzepatide's potential as a targeted therapy for MASLD, a condition with limited effective treatment options. Positive findings could pave the way for larger, more defini…
Finding effective strategies to prevent weight regain after discontinuing GLP-1 agonists is critically important for long-term obesity management and patient well-being. This trial could provide evidence for new stand…
Understanding the unique pathophysiology of Normal-Weight Type 2 Diabetes (NWD) is crucial, as these individuals may not benefit from traditional weight-loss-focused interventions for T2D. This study's findings could …
This Phase II trial is significant because it addresses a critical unmet need for effective weight management in adult survivors of childhood Acute Lymphoblastic Leukemia (ALL), a group highly susceptible to cardiomet…
This trial is critically important because it addresses a significant gap in our understanding of how tirzepatide performs in a vulnerable and growing patient group. The findings could establish a new therapeutic opti…
This groundbreaking GLP-1 brain atlas provides a foundational neuroanatomical map, offering unprecedented insights into the diverse physiological roles of GLP-1 beyond its well-known glucose-lowering effects. By preci…
This research provides crucial insights into the genetic underpinnings of GLP-1 RA response, paving the way for personalized treatment strategies. By identifying individuals most likely to benefit or experience advers…
This real-world evidence suggests that Tirzepatide could be a safe and effective therapeutic option for managing obesity and type 2 diabetes in kidney transplant recipients, a population often excluded from major clin…
This study addresses a critical need for practical, accessible dietary recommendations to complement GLP-1 RA therapy, potentially enhancing patient outcomes beyond just weight loss. If successful, it could provide a …
This study is pivotal as it explores a novel, multimodal approach to pre-surgical optimization for a high-risk patient population. If successful, the findings could revolutionize the standard of care for obese patient…
This study provides initial evidence that combining LY3457263 with tirzepatide could represent a more potent and effective strategy for treating obesity than existing monotherapies. The favorable safety profile and en…
This clinical trial is profoundly significant as it explores a novel and promising therapeutic approach for ADPKD, a disease with limited treatment options and a high burden on patients. If successful, this research c…
If successful, this pilot study could pave the way for a novel pre-surgical intervention to improve outcomes for prostate cancer patients. Demonstrating the feasibility of tirzepatide-assisted weight loss could lead t…
Had it been completed, this registry would have provided an invaluable real-world dataset for understanding the long-term trajectory of obesity and metabolic diseases, offering insights into how these conditions evolv…
If tirzepatide proves safe and effective, it could represent a significant therapeutic advancement for individuals with Type 1 Diabetes who struggle with obesity or overweight. Currently, there are limited pharmacolog…